IEX · Idex Corp /De/ - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.27B | $3.27B | $3.18B | $2.76B | $2.35B |
| Cost of Revenue | $1.92B | $1.82B | $1.83B | $1.75B | $1.54B | $1.32B |
| Gross Profit | $1.54B | $1.45B | $1.45B | $1.43B | $1.22B | $1.03B |
| R&D | $70.00M | $67.40M | $68.40M | $61.40M | $50.10M | $48.20M |
| SG&A | $818.80M | $758.70M | $703.50M | $652.70M | $578.20M | $494.94M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $75.80M | $68.50M | $152.10M | $119.70M | $103.00M | $83.50M |
| Operating Income | $699.30M | $677.20M | $732.50M | $751.40M | $637.00M | $520.71M |
| Interest Expense | - | - | $51.70M | $40.70M | $41.00M | $44.75M |
| Income Tax | $150.10M | $134.70M | $164.70M | $162.70M | $130.50M | $92.56M |
| Net Income | $483.20M | $505.00M | $596.10M | $586.90M | $449.40M | $377.78M |
| EPS - Basic | $6.41 | $6.66 | $7.87 | $7.74 | $5.91 | $4.98 |
| EPS - Diluted | $6.41 | $6.64 | $7.85 | $7.71 | $5.88 | $4.94 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $580.00M | $620.80M | $534.30M | $430.20M | $855.40M | $1.03B |
| Accounts Receivable | $511.90M | $461.00M | $419.00M | $431.30M | $354.90M | $288.29M |
| Inventory | $479.40M | $429.70M | $420.80M | $470.90M | $370.40M | $289.91M |
| Accounts Payable | $224.70M | $197.80M | $179.70M | $208.90M | $178.80M | $151.99M |
| Current Assets | $1.64B | $1.59B | $1.45B | $1.40B | $1.68B | $1.66B |
| Total Assets | $6.93B | $6.75B | $5.87B | $5.51B | $4.92B | $4.41B |
| Current Liabilities | $575.40M | $629.70M | $500.30M | $543.60M | $480.00M | $399.06M |
| Long-term Debt | $1.82B | $1.86B | $1.33B | $1.47B | $1.19B | $1.04B |
| Total Liabilities | $2.90B | $2.95B | $2.32B | $2.47B | $2.11B | $1.87B |
| Stockholders' Equity | $4.03B | $3.79B | $3.54B | $3.04B | $2.80B | $2.54B |
| Retained Earnings | $4.50B | $4.23B | $3.93B | $3.53B | $3.13B | $2.84B |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $680.40M | $668.10M | $716.70M | $557.40M | $565.30M | $569.27M |
| Investing Cash Flow | ($137.60M) | ($1.01B) | ($283.80M) | ($917.20M) | ($698.10M) | ($172.58M) |
| Financing Cash Flow | ($632.60M) | $465.90M | ($344.70M) | ($37.80M) | ($9.50M) | ($42.60M) |
| CapEx | $63.60M | $65.10M | $89.90M | $68.00M | $72.70M | $51.55M |
| Free Cash Flow | $616.80M | $603.00M | $626.80M | $489.40M | $492.60M | $517.73M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 44.5% | 44.2% | 44.2% | 44.8% | 44.3% | 43.7% |
| Operating margin | 20.2% | 20.7% | 22.4% | 23.6% | 23.0% | 22.1% |
| EBITDA margin | 22.4% | 22.8% | 27.0% | 27.4% | 26.8% | 25.7% |
| Net margin | 14.0% | 15.4% | 18.2% | 18.4% | 16.3% | 16.1% |
| Free cash flow margin | 17.8% | 18.4% | 19.1% | 15.4% | 17.8% | 22.0% |
| FCF / Net income | 1.28 | 1.19 | 1.05 | 0.83 | 1.10 | 1.37 |
| R&D / Revenue | 2.0% | 2.1% | 2.1% | 1.9% | 1.8% | 2.0% |
| SG&A / Revenue | 23.7% | 23.2% | 21.5% | 20.5% | 20.9% | 21.0% |
| Effective tax rate | 23.7% | 21.1% | 21.6% | 21.7% | 22.5% | 19.7% |
| Return on assets | 7.0% | 7.5% | 10.2% | 10.6% | 9.1% | 8.6% |
| Return on equity | 12.0% | 13.3% | 16.8% | 19.3% | 16.0% | 14.9% |
| Return on invested capital | 9.1% | 9.5% | 11.8% | 13.1% | 12.4% | 11.7% |
| Liquidity | ||||||
| Current ratio | 2.86 | 2.53 | 2.89 | 2.57 | 3.50 | 4.15 |
| Quick ratio | 2.02 | 1.85 | 2.05 | 1.71 | 2.72 | 3.43 |
| Cash ratio | 1.01 | 0.99 | 1.07 | 0.79 | 1.78 | 2.57 |
| Leverage | ||||||
| Debt / Equity | 0.45 | 0.49 | 0.37 | 0.48 | 0.42 | 0.41 |
| Debt / Assets | 0.26 | 0.28 | 0.23 | 0.27 | 0.24 | 0.24 |
| Debt / EBITDA | 2.35 | 2.49 | 1.50 | 1.69 | 1.61 | 1.73 |
| Interest coverage | - | - | 14.2x | 18.5x | 15.5x | 11.6x |
| Equity multiplier | 1.72 | 1.78 | 1.66 | 1.81 | 1.75 | 1.74 |
| Liabilities / Assets | 0.42 | 0.44 | 0.40 | 0.45 | 0.43 | 0.42 |
| Efficiency | ||||||
| Asset turnover | 0.50 | 0.48 | 0.56 | 0.58 | 0.56 | 0.53 |
| Inventory turnover | 4.00 | 4.24 | 4.34 | 3.73 | 4.16 | 4.57 |
| Days sales outstanding | 54d | 51d | 47d | 49d | 47d | 45d |
| Days inventory outstanding | 91d | 86d | 84d | 98d | 88d | 80d |
| Days payable outstanding | 43d | 40d | 36d | 43d | 42d | 42d |
| Cash conversion cycle | 102d | 98d | 95d | 104d | 92d | 83d |
| Valuation | ||||||
| P / E | 27.8x | 31.5x | 27.7x | 29.6x | 40.2x | 40.3x |
| P / B | 3.3x | 4.2x | 4.7x | 5.7x | 6.4x | 6.0x |
| P / S | 3.9x | 4.9x | 5.0x | 5.5x | 6.5x | 6.5x |
| EV / EBITDA | 18.9x | 23.0x | 19.5x | 21.1x | 24.9x | 25.2x |
| Growth | ||||||
| Revenue growth (YoY) | 5.8% | -0.2% | 2.9% | 15.1% | 17.6% | -5.7% |
| Revenue CAGR (3y) | 2.8% | 5.7% | 11.7% | 8.5% | 3.6% | 0.9% |
| Revenue CAGR (5y) | 8.0% | 5.6% | 5.7% | 6.8% | 5.5% | 3.1% |
| Gross profit growth (YoY) | 6.5% | -0.1% | 1.4% | 16.5% | 19.2% | -8.7% |
| Operating income growth (YoY) | 3.3% | -7.5% | -2.5% | 18.0% | 22.3% | -10.1% |
| Net income growth (YoY) | -4.3% | -15.3% | 1.6% | 30.6% | 19.0% | -11.2% |
| EPS growth (YoY) | -3.5% | -15.4% | 1.8% | 31.1% | 19.0% | -11.2% |
| EPS CAGR (3y) | -6.0% | 4.1% | 16.7% | 11.5% | 3.6% | 4.3% |
| EPS CAGR (5y) | 5.3% | 3.6% | 8.2% | 12.1% | 10.7% | 6.4% |
| FCF growth (YoY) | 2.3% | -3.8% | 28.1% | -0.6% | -4.9% | 8.5% |
| FCF CAGR (5y) | 3.6% | 4.8% | 8.2% | 4.7% | 6.4% | 10.3% |
| Book value growth (YoY) | 6.1% | 7.2% | 16.5% | 8.4% | 10.3% | 12.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$3.46B totalHealth And Science Technologies$1.49B · 43.1%
Fluid And Metering Technologies$1.22B · 35.4%
Fire And Safety Diversified Products$744.30M · 21.5%
Geographic
$1.50B totalUS$695.70M · 46.5%
Europe$448.40M · 30.0%
Asia$292.30M · 19.5%
Other Geographical Areas$34.40M · 2.3%
North America Excluding United States$24.70M · 1.7%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
2.06
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
8/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Pumps & Pumping Equipment
Comparing IDEX CORP /DE/ against the 5 most active filers in the same SIC group.
Dividends
$2.86/share trailing 12 months · +2.9% YoY
| Ex-date | Per share |
|---|---|
| May 22, 2026 | $0.7300 |
| Jan 16, 2026 | $0.7100 |
| Oct 10, 2025 | $0.7100 |
| Jul 11, 2025 | $0.7100 |
| May 19, 2025 | $0.7100 |
| Jan 17, 2025 | $0.6900 |
| Oct 11, 2024 | $0.6900 |
| Jul 12, 2024 | $0.6900 |
| May 16, 2024 | $0.6900 |
| Jan 11, 2024 | $0.6400 |
| Oct 12, 2023 | $0.6400 |
| Jul 13, 2023 | $0.6400 |
| Jun 8, 2023 | $0.6400 |
| Jan 12, 2023 | $0.6000 |
| Oct 13, 2022 | $0.6000 |
| Jul 14, 2022 | $0.6000 |
| May 16, 2022 | $0.6000 |
| Jan 13, 2022 | $0.5400 |
| Oct 14, 2021 | $0.5400 |
| Jul 14, 2021 | $0.5400 |
| May 21, 2021 | $0.5400 |
| Jan 13, 2021 | $0.5000 |
| Oct 14, 2020 | $0.5000 |
| Jul 15, 2020 | $0.5000 |